SeqLL, Inc. (SQL)
|Net Income (ttm)||-1.05M|
SeqLL is an established life sciences instrumentation and research services company engaged in the development of scientific assets and novel intellectual property across multiple “omics” fields (e.g. genomics, proteomics, transcriptomics...). Our mission is to empower researchers with improved genetic tools that enable scientists and physicians to better understand the molecular mechanisms of disease and the underlying biological systems. We believe our proprietary sequencing technology platform has critical advantages over existing Next G... [Read more...]
Laboratory Analytical Instruments
|IPO Date |
|Stock Exchange |
|Ticker Symbol |
In 2020, SeqLL's revenue was $329,495, a decrease of -38.20% compared to the previous year's $533,129. Losses were -$1.05 million, -57.74% less than in 2019.